Response and survival benefit with chemoimmunotherapy in Epstein ‐Barr virus‐positive diffuse large B‐cell lymphoma
Hematological Oncology,Volume 36, Issue 1, Page 93-97, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 22, 2017 Category: Hematology Source Type: research
Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival
Hematological Oncology,Volume 36, Issue 1, Page 128-135, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 22, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 93-97, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 22, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 128-135, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 22, 2017 Category: Hematology Source Type: research
Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma
Hematological Oncology,Volume 36, Issue 1, Page 238-244, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 19, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 238-244, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 19, 2017 Category: Hematology Source Type: research
Outcome of patients older than 80 years with diffuse large B‐cell lymphoma (DLBCL) treated with “standard” immunochemotherapy: A large retrospective study from 4 institutions
Hematological Oncology,Volume 36, Issue 1, Page 84-92, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 16, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 84-92, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 16, 2017 Category: Hematology Source Type: research
Lecture Notes: Oncology, 3rd Edition. Mark Bower and Jonathan Waxman. Wiley ‐Blackwell, 2016, Ebook/Paperback, 352 pp., Prices starting from 23.80 euros
(Source: Hematological Oncology)
Source: Hematological Oncology - June 16, 2017 Category: Hematology Authors: Francesco Bertoni Tags: BOOK REVIEW Source Type: research
Issue Information
No abstract is available for this article. (Source: Hematological Oncology)
Source: Hematological Oncology - June 16, 2017 Category: Hematology Tags: ISSUE INFORMATION Source Type: research
Angiopoietin ‐2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie‐2 receptor engagement
Hematological Oncology,Volume 36, Issue 1, Page 372-375, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 4, 2017 Category: Hematology Source Type: research
Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy
Hematological Oncology,Volume 36, Issue 1, Page 316-319, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 4, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 372-375, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 4, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 316-319, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - June 4, 2017 Category: Hematology Source Type: research
Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B ‐cell precursor acute lymphoblastic leukaemia
Abstract
Glucocorticoid (GC) shows antileukaemic activity via binding to the GC receptor (GR). The human GR gene has 4 splicing variants besides the functional isoform GRα, but their significance in GC sensitivity of acute lymphoblastic leukaemia (ALL) has been inconsistent. Additionally, several studies evaluated the relevance of GR gene single nucleotide polymorphisms (SNPs) in the GC sensitivity of ALL, but the current cumulative evidence appears inconclusive. Addressing limitations in previous studies, we used a large series of B‐cell precursor ALL (BCP‐ALL) cell lines established from Japanese patients to compreh...
Source: Hematological Oncology - June 1, 2017 Category: Hematology Authors: Meixian Huang, Takeshi Inukai, Keiko Kagami, Masako Abe, Tamao Shinohara, Atsushi Watanabe, Shinpei Somazu, Hiroko Oshiro, Kumiko Goi, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Kevin Y. Urayama, Kanji Sugita Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
